Cary Street Partners Investment Advisory’s Reata Pharmaceuticals, Inc. Class A Common Stock RETA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2021
Q1
Sell
-32,472
Closed -$4.01M 424
2020
Q4
$4.01M Buy
+32,472
New +$4.01M 0.77% 26